DePuy Synthes

Johnson & Johnson Medical Shanghai entered into co-marketing and R&D agreements with Tinavi to bring Tinavi's spinal and trauma robotic solution to the China orthopedics implant market.

DePuy Synthes Products, Inc. signed a definitive agreement to acquire the assets of JointPoint, Inc., including its surgeon-friendly navigation software for hip replacement. Financial terms were not disclosed.

DePuy Synthes announced a €36 million investment in its Ireland Innovation Centre in Ringaskiddy, Cork, to expand R&D in 3D printing, coatings, and surface treatments. The project will create 30 jobs.

Johnson & Johnson Medical GmbH, a subsidiary of Johnson & Johnson Medical Devices Companies, acquired Emerging Technologies GmbH for its 3-D printed titanium interbody implants for spinal fusion surgery.

DePuy Synthes Sales, Inc. entered into an exclusive agreement with Ortho Development Corporation to co-promote in the U.S. its KASM Knee Articulating Spacer Mold, a sterile disposable cement spacer mold for patients with infection after primary knee surgery.

DePuy Synthes, part of Johnson & Johnson Medical Devices, has entered into a commercial agreement with Australian developer 360 KNEE SYSTEMS. The platform will be available with DePuy Synthes' ATTUNE Knee System in Australia and New Zealand.

DePuy Synthes, part of Johnson & Johnson Medical Devices, has signed a definitive agreement to acquire the assets of Medical Enterprises Distribution LLC, including the ME1000 Surgical Impactor tool used in hip replacement surgery. Financial terms were not disclosed.

DePuy Synthes announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack miniature radiofrequency tracking technology from MinMaxMedical for use across its Joints portfolio, including shoulder, hip and knee, for navigation and robotic applications.

DePuy Synthes, a Johnson & Johnson company, partnered with Johnson & Johnson Finance Corporation to provide financing options for its Hana Orthopedic Surgery Table.

Centinel Spine, LLC acquired the worldwide assets of the prodisc Total Disc Replacement portfolio from DePuy Synthes Products, Inc. The portfolio includes prodisc C, prodisc L, prodisc VIVO, prodisc NOVA, prodisc O and DISCOVER Cervical. The acquisition complements Centinel Spine's existing spinal implant portfolio.

The Federal Trade Commission approved Integra LifeSciences' request to purchase DePuy Synthes’ Codman Neuro division.

JointPoint signed an exclusive agreement with DePuy Synthes to market JointPoint’s noninvasive computer navigation software for hip replacement surgery.

Centinel Spine entered into an asset purchase agreement to acquire the ProDisc Total Disc Replacement portfolio from DePuy Synthes, with closing expected in November 2017.

Johnson & Johnson subsidiary DePuy Synthes secured a $32,994,565 contract from the U.S. Department of Defense for medical surgical products, with options for up to nine years.

Johnson & Johnson subsidiary DePuy Synthes signed an exclusive agreement with JointPoint to co-market its hip surgery navigation software platform in the U.S. The companies plan to start co-marketing in the second half of 2017.

DePuy Synthes Products, Inc., part of Johnson & Johnson Medical Devices Companies, has acquired Innovative Surgical Solutions, LLC (doing business as Sentio, LLC), a company based in Wixom, Michigan that markets nerve localization technology for spine surgery. Financial terms were not disclosed.

DePuy Synthes was awarded a national contract from the U.S. Department of Defense to supply up to $260 million worth of orthopaedic products to the Defense Logistics Agency's electronic catalog for U.S. military medical treatment facilities worldwide.

DePuy Synthes has entered into an asset purchase and development agreement with Interventional Spine to acquire its expandable cage and MIS technologies for spinal fusion.